Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation ; volume:14 ; number:1 ; day:6 ; month:3 ; year:2024 ; pages:1-22 ; date:12.2024
Scientific reports ; 14, Heft 1 (6.3.2024), 1-22, 12.2024
- Urheber
-
Sardzikova, Sara
Andrijkova, Kristina
Svec, Peter
Beke, Gabor
Klucar, Lubos
Minarik, Gabriel
Bielik, Viktor
Kolenova, Alexandra
Soltys, Katarina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-56242-8
- URN
-
urn:nbn:de:101:1-2405100911216.715606695444
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sardzikova, Sara
- Andrijkova, Kristina
- Svec, Peter
- Beke, Gabor
- Klucar, Lubos
- Minarik, Gabriel
- Bielik, Viktor
- Kolenova, Alexandra
- Soltys, Katarina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnostics and therapy of paediatric patients with febrile neutropenia
Febrile neutropenia : with 32 tables
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Diagnostics and therapy of paediatric patients with febrile neutropenia
Febrile neutropenia : with 32 tables
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Diagnostics and therapy of paediatric patients with febrile neutropenia
Febrile neutropenia : with 32 tables
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Time to antibiotics and outcomes in cancer patients with febrile neutropenia